AccScience Publishing / EJMO / Online First / DOI: 10.36922/EJMO025520538
Submit to EJMO
Cite this article
2
Download
24
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
ORIGINAL RESEARCH ARTICLE

Sex differences in thyroid hormone and ferritin levels and short-term functional outcomes in acute ischemic stroke

Yang Li1,2,3† ,  Xiaofei Niu4† ,  Yaxin Zhang1,2,3 ,  Wenwen Wang5 ,  Ye Li1,2,3 ,  Yanan Wang1,2,3 ,  Xiaosu Guo1,2,3 ,  Zhi Yuan Shen1,2,3 ,  Yuan Xing1,2,3 ,  Shu Juan Tian1,2,3* ,  Xin Guo1,2,3*
Show Less
1 Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
2 Department of Neurology, Hebei Hospital, Xuanwu Hospital, Capital Medical University, Shijiazhuang, Hebei, China
3 Neuromedical Technology Innovation Center of Hebei Province, Shijiazhuang, Hebei, China
4 Department of Traditional Chinese Medicine, Huanghua Municipal People’s Hospital, Cangzhou, Hebei, China
5 Department of Science Education, Huanghua Municipal People’s Hospital, Cangzhou, Hebei, China
†These authors contributed equally to this work.
EJMO, 025520538 https://doi.org/10.36922/EJMO025520538
Received: 23 December 2025 | Revised: 28 January 2026 | Accepted: 28 February 2026 | Published online: 14 April 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Download PDF
XML
Cite
Abstract

Introduction: Acute ischemic stroke (AIS) is a major cause of death and disability worldwide. Thyroid hormones and ferritin are involved in neuronal recovery and iron metabolism after cerebral ischemia. However, their association with short-term functional outcomes in AIS, particularly potential sex-specific differences, remains unclear. This study investigated the relationship between thyroid hormone and ferritin levels and short-term functional prognosis in AIS patients.

Objective: This study aims to investigate the relationship between thyroid hormones and ferritin and the prognosis of patients with AIS, and to evaluate whether there is a sex-specific difference, which could provide a reference for predicting the short-term functional outcome of patients with AIS.

Methods: A total of 961 patients with AIS were recruited from January 2019 to December 2021. Patient demographic and clinical data were collected, and thyroid hormones (free triiodothyronine [FT3], free thyroxine, total triiodothyronine [TT3], and total thyroxine) and ferritin levels were measured on admission. Statistical methods, including t-test, chi-square test, logistic regression analysis, and correlation analysis, were used to analyze the predictive value of thyroid hormone and ferritin levels regarding short-term functional outcome in AIS patients stratified by sex.

Results: Lower FT3 and TT3 levels and higher ferritin levels were observed in patients with poor outcomes (p < 0.05). After adjustment for confounders, the findings revealed that TT3 was independently associated with poor short-term functional outcome (odds ratio = 0.405, 95% confidence interval: 0.203–0.807, p = 0.010). In sex-stratified analyses, TT3 levels were statistically correlated with poor outcomes among male patients, whereas free thyroxine, TT3, and ferritin were associated with poor outcomes in female patients. FT3 and TT3 were negatively correlated with modified Rankin Scale scores in both sexes, while ferritin showed a positive correlation with poor outcome only in female patients.

Conclusion: Thyroid hormone and ferritin levels can serve as potential predictors of short-term functional outcome in patients with AIS, and sex-specific differences exist in their effects.

Keywords
Acute ischemic stroke
Short-term functional outcome
Thyroid hormones
Iron metabolism
Ferritin
Funding
This work was supported by the National Natural Science Foundation of China (No. 82301458), the Nature Science Foundation of Hebei Province (H2024206372), Hebei Province Government-funded Excellent Talents Project in Clinical Medicine (No. ZF2024147), the Medical Science Research Project of Hebei Province (No. 20230984 and 20240529), the Project of Traditional Chinese Medicine of Hebei Province (No. 2023064), and the “Spark” scientific research project of the First Hospital of Hebei Medical University (No. XH202314).
Conflict of interest
The authors declare they have no conflict of interest.
References
  1. Elkind MSV. Stroke Science and Care Since the Founding of the American Heart Association. Circulation. 2024;149(19):1469-1470. doi: 10.1161/circulationaha.123.065471

 

  1. Potter TBH, Tannous J, Vahidy FS. A Contemporary Review of Epidemiology, Risk Factors, Etiology, and Outcomes of Premature Stroke. Curr Atheroscler Rep. 2022;24(12):939- 948. doi: 10.1007/s11883-022-01067-x

 

  1. O’Dell   Stroke  Rehabilitation  and  Motor Recovery. Continuum (Minneap Minn). 2023;29(2):605-627. doi: 10.1212/con.0000000000001218

 

  1. Wu S, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 2019;18(4):394-405. doi: 10.1016/s1474-4422(18)30500-3

 

  1. Tu WJ, Wang LD. China stroke surveillance report 2021. Mil Med Res. 2023;10(1):33. doi: 10.1186/s40779-023-00463-x

 

  1. Alcaide Martin A, Mayerl S. Local Thyroid Hormone Action in Brain Development. Int J Mol Sci. 2023;24(15):12352. doi: 10.3390/ijms241512352

 

  1. Talhada D, Santos CRA, Gonçalves I, Ruscher K. Thyroid Hormones in the Brain and Their Impact in Recovery Mechanisms After Stroke. Front Neurol. 2019;10:1103. doi: 10.3389/fneur.2019.01103

 

  1. Fu J, Zhao Q, Li J, Chen X, Peng L. Association between thyroid hormone levels in the acute stage of stroke and risk of poststroke depression: A meta-analysis. Brain Behav. 2023;14(1):e3322. doi: 10.1002/brb3.3322

 

  1. Papaleontiou M, Levine DA, Reyes-Gastelum D, Hawley ST, Banerjee M, Haymart MR. Thyroid Hormone and Incident Stroke. J Clin Endocrinol Metab. 2021;106(10):e3890-e3900. doi: 10.1210/clinem/dgab444

 

  1. Zheng W, Wang Y, Xia Z, Liu D. Serum ferritin and risk of stroke: a meta-analysis of observation studies. Front Neurol. 2025;16:1539407. doi: 10.3389/fneur.2025.1539407

 

  1. Sakib AA, Miah MAH, Alam MK, et al. Relation of Serum Ferritin Level with Severity of Neurological Disability among Patients with Acute Ischemic Stroke. Mymensingh Med J. 2024;33(4):973-979.

 

  1. Xia X, Liu J, Fang W, Chen Z, Wang J, Xu H. The association between ferritin levels and all-cause mortality in stroke patients. Front Neurol. 2024;15:1386408. doi: 10.3389/fneur.2024.1386408

 

  1. Shafia S, Khoramirad A, Akhoundzadeh K. Thyroid hormones and stroke, the gap between clinical and experimental studies. Brain Res Bull. 2024;213:110983. doi: 10.1016/j.brainresbull.2024.110983

 

  1. Razavi AC, Troy AL, Patel J, et al. Future of Stroke Prevention: 7 Updates in the 2024 AHA/ASA Primary Prevention of Stroke Guideline. JACC Adv. 2025;4(6):101724. doi: 10.1016/j.jacadv.2025.101724

 

  1. Liu Z, Chopp M. Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke. Prog Neurobiol. 2016;144:103-120. doi: 10.1016/j.pneurobio.2015.09.008

 

  1. Morte B, Gil-Ibáñez P, Bernal J. Regulation of Gene Expression by Thyroid Hormone in Primary Astrocytes: Factors Influencing the Genomic Response. Endocrinology. 2018;159(5):2083-2092. doi: 10.1210/en.2017-03084

 

  1. Fujiwara Y, Miyasaka Y, Ninomiya A, et al. Effects of Perfluorooctane Sulfonate on Cerebellar Cells via Inhibition of Type 2 Iodothyronine Deiodinase Activity. Int J Mol Sci. 2023;24(16):12765. doi: 10.3390/ijms241612765

 

  1. Gozlan E, Lewit-Cohen Y, Frenkel D. Sex Differences in Astrocyte Activity. Cells. 2024;13(20):1724. doi: 10.3390/cells13201724

 

  1. Novelle MG, Camacho-Morales A, Martínez De Morentin PB. Editorial: Role of estrogens as key regulators of energy homeostasis. Front Endocrinol. 2023;14:1279619. doi: 10.3389/fendo.2023.1279619

 

  1. Jin Y, Zhuang Y, Liu M, Che J, Dong X. Inhibiting ferroptosis: A novel approach for stroke therapeutics. Drug Discov Today. 2021;26(4):916-930. doi: 10.1016/j.drudis.2020.12.020

 

  1. Zhu M, Peng L, Huo S, et al. STAT3 signaling promotes cardiac injury  by  upregulating  NCOA4-mediated ferritinophagy and ferroptosis in high-fat-diet fed mice. Free Radic Biol Med. 2023;201:111-125. doi: 10.1016/j.freeradbiomed.2023.03.003

 

  1. Arosio P, Cairo G, Bou-Abdallah F. A Brief History of Ferritin, an Ancient and Versatile Protein. Int J Mol Sci. 2024;26(1):206. doi: 10.3390/ijms26010206

 

  1. Li C, Sun G, Chen B, et al. Nuclear receptor coactivator 4-mediated ferritinophagy contributes to cerebral ischemia- induced ferroptosis in ischemic stroke. Pharmacol Res. 2021;174:105933. doi: 10.1016/j.phrs.2021.105933

 

  1. Lee J, Hyun DH. The Interplay between Intracellular Iron Homeostasis and Neuroinflammation in Neurodegenerative Diseases. Antioxidants. 2023;12(4):918. doi: 10.3390/antiox12040918

 

  1. Taroza S, Rastenytė D, Burkauskas J, Podlipskytė A, Mickuvienė N. Lower serum free triiodothyronine levels are associated with symptoms of depression after ischemic stroke. J Psychosom Res. 2019;122:29-35. doi: 10.1016/j.jpsychores.2019.04.018

 

  1. He J, Fu F, Zhang W, Zhan Z, Cheng Z. Prognostic significance of the clinical and radiological haemorrhagic transformation subtypes in acute ischaemic stroke: A systematic review and meta-analysis. Eur J Neurol. 2022;29(11):3449-3459. doi: 10.1111/ene.15482
Share
Back to top
Eurasian Journal of Medicine and Oncology, Electronic ISSN: 2587-196X Print ISSN: 2587-2400, Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept